FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluconazole In Dextrose 5% In Plastic Container, and what generic alternatives are available?
Fluconazole In Dextrose 5% In Plastic Container is a drug marketed by Hikma Farmaceutica, Hospira, Mylan Labs Ltd, and Woodward. and is included in four NDAs.
The generic ingredient in FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER is fluconazole. There are twenty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the fluconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluconazole In Dextrose 5% In Plastic Container
A generic version of FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as fluconazole by CHARTWELL on July 29th, 2004.
Summary for FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 272 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
FEMPHARMA Kft. | N/A |
PPD | Phase 1 |
Rehab Werida | N/A |
See all FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
Pharmacology for FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug Class | Azole Antifungal |
Mechanism of Action | Cytochrome P450 2C19 Inhibitors Cytochrome P450 2C9 Inhibitors Cytochrome P450 3A4 Inhibitors |